Customs Duty Scrapped on 17 Cancer Drugs
Union Finance Minister Nirmala Sitharaman has announced major relief for patients battling cancer and rare diseases in the Union Budget 2026. The Budget removes basic customs duty on 17 cancer-related drugs and extends duty exemptions to treatments for seven rare diseases, aiming to reduce the financial burden of life-saving therapies that are largely dependent on imports. Relief for Cancer Patients Through Duty Exemption Presenting the Budget in Parliament, Sitharaman said the removal of basic customs duty on 17 cancer drugs is intended to make advanced and complex treatments more affordable. Imported oncology medicines currently attract customs duty, which significantly inflates retail prices. By eliminating this levy, the government expects a direct reduction in treatment costs across several high-value cancer therapies, improving access for patients across income groups. Impact on Treatment Costs and Access Health experts have noted that imported medicines form a substa...